Arrow Fat Left Icon Arrow Fat Right Icon Arrow Right Icon Cart Icon Close Circle Icon Expand Arrows Icon Facebook Icon Instagram Icon Twitter Icon Youtube Icon Hamburger Icon Information Icon Down Arrow Icon Mail Icon Mini Cart Icon Person Icon Ruler Icon Search Icon Shirt Icon Triangle Icon Bag Icon Play Video

Diagnostics on demand.
Providing you with simple, easy access to world-leading laboratories that deliver the broadest range of wellness focussed diagnostic testing services.
For health professionals and patients across the UK and around the world.

Doctors Data - DD002

CardioMetabolic Serum

CardioMetabolic Blood (Venous) Turn Around Time: 12 Days
Recommended: Contact practitioner before placing order
Turn Around Time: 12 Days

Description

This advanced test evaluates risk factors for cardiovascular disease (CVD) plus metabolic factors associated with metabolic syndrome and type II diabetes. In addition to the traditional CVD risk factors, the test includes much more clinically sensitive atherogenic lipoprotein sub-species, the primary apolipoproteins, arterial inflammation and the activity of the lipoprotein- associated phospholipase- A2 (PLAC®). PLAC® activity is a very sensitive indicator of active atherogenesis and instability of advanced arterial plaque. Metabolic syndrome (MetS) is centered around insulin resistance and atherogenic dyslipoproteinemia, and is a risk factor associated with CVD and kidney disease. The test includes cystatin C to better assess glomerular filtration, and 1,5-anhydroglucitol (Glycomark®) that is a better indicator of hyperglycemic episodes than HbA1C. The primary adipokines associated with insulin sensitivity and hepatic fatty acid metabolism are also addressed

Methodology

Enzymatic Immunoturbidimetric
Enzyme Immunoassay
Kinetic Jaffe

When should I use

Useful for patients with
Family or personal history of CVD
Excess abdominal fat
Obesity
Insulin resistance
Fatty liver disease

Other Details

-
  • Adiponectin
  • Apo B : Apo A-1
  • Apolipoprotein A1
  • Apolipoprotein B
  • Creatinine
  • CRP (hs)
  • Cystatin C
  • eGFR
  • Glucose
  • Glycomark (1
  • HDL cholesterol
  • Homocysteine
  • Insulin
  • LDL-C : HDL-C
  • LDL-cholesterol (calculated)
  • Leptin
  • Leptin : Adiponectin ratio
  • Lp(a)
  • Non-HDL cholesterol (calculated)
  • Oxidised LDL
  • Oxidised LDL : HDL-C
  • PLAC (LP-PLA2 Activity)
  • Small dense LDL
  • Small dense LDL-C : LDL-C
  • Total cholesterol
  • Total cholesterol : HDL-C
  • Triglycerides
  • VDL cholesterol (calculated)

View Details

Description

This advanced test evaluates risk factors for cardiovascular disease (CVD) plus metabolic factors associated with metabolic syndrome and type II diabetes. In addition to the traditional CVD risk factors, the test includes much more clinically sensitive atherogenic lipoprotein sub-species, the primary apolipoproteins, arterial inflammation and the activity of the lipoprotein- associated phospholipase- A2 (PLAC®). PLAC® activity is a very sensitive indicator of active atherogenesis and instability of advanced arterial plaque. Metabolic syndrome (MetS) is centered around insulin resistance and atherogenic dyslipoproteinemia, and is a risk factor associated with CVD and kidney disease. The test includes cystatin C to better assess glomerular filtration, and 1,5-anhydroglucitol (Glycomark®) that is a better indicator of hyperglycemic episodes than HbA1C. The primary adipokines associated with insulin sensitivity and hepatic fatty acid metabolism are also addressed

Methodology

Enzymatic Immunoturbidimetric
Enzyme Immunoassay
Kinetic Jaffe

When should I use

Useful for patients with
Family or personal history of CVD
Excess abdominal fat
Obesity
Insulin resistance
Fatty liver disease

Other Details

-

View Analytes

  • Adiponectin
  • Apo B : Apo A-1
  • Apolipoprotein A1
  • Apolipoprotein B
  • Creatinine
  • CRP (hs)
  • Cystatin C
  • eGFR
  • Glucose
  • Glycomark (1
  • HDL cholesterol
  • Homocysteine
  • Insulin
  • LDL-C : HDL-C
  • LDL-cholesterol (calculated)
  • Leptin
  • Leptin : Adiponectin ratio
  • Lp(a)
  • Non-HDL cholesterol (calculated)
  • Oxidised LDL
  • Oxidised LDL : HDL-C
  • PLAC (LP-PLA2 Activity)
  • Small dense LDL
  • Small dense LDL-C : LDL-C
  • Total cholesterol
  • Total cholesterol : HDL-C
  • Triglycerides
  • VDL cholesterol (calculated)

View Instructions

English